newsfilter
← Latest News
GlobeNewswire·

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

~ Held Type A meeting with FDA to discuss AMT-130 for Huntington's disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of 2026 ~ ~